ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin? [Anatol J Cardiol]
Anatol J Cardiol. 2007; 7(2): 217-219

Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?

Yüksel Çavuşoğlu1
Department of Cardiology and, Faculty of Medicine, Eskisehir Osmangazi University, Eskişehir-Turkey

Kronik atriyal fibrilasyonda ximelagatran warfarin’in alternatifi olamaz/Atriyal fibrilasyonda ximelagatran ile antitrombotik tedavi: Ximelagatran warfarin’e alternatif olabilir mi?

Yüksel Çavuşoğlu1
Department of Cardiology and, Faculty of Medicine, Eskisehir Osmangazi University, Eskişehir-Turkey

Yüksel Çavuşoğlu. Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?. Anatol J Cardiol. 2007; 7(2): 217-219
Manuscript Language: English
TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Similar articles PubMed Google Scholar


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search



  1. Home
  2. About
  3. Abstrating and Indexing
  1. Copyright
  2. Aim and Scope
  3. Editorial Board
  1. Instructions for Authors
  2. ICMJE Recommendations
  3. Contact

Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media. 
LookUs  &   Online Makale